FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be used to prevent the development of macular rupture in patients with vitreomacular traction syndrome (VMTS) in the presence of an existing macular rupture in the paired eye. Laser coagulates are applied in the macular area, some 200 mcm from the edge of the avascular zone, around the circumference with the center in the fovea. Following modes are used: a wavelength of 577 nm, a power of 50 mW, a pulse duration of 0.03–0.05 s, a coagulum diameter of 100 mcm. Distance between coagulates is 100 microns. Number of coagulates is from 10 to 12.
EFFECT: method provides stabilization of the most corrected visual acuity and retinal photosensitivity.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF COMBINED LASER TREATMENT OF INITIAL STAGE OF EPIRETINAL FIBROSIS | 2016 |
|
RU2634684C1 |
| METHOD OF TREATING MACULAR RUPTURE COMPLICATED BY DRUSENOID DETACHMENT OF RETINAL PIGMENT EPITHELIUM | 2022 |
|
RU2820489C1 |
| METHOD FOR TREATMENT OF MACULAR RETINAL FOLDING | 2021 |
|
RU2776768C1 |
| METHOD FOR EVALUATING EFFECTIVENESS OF TREATING FLOATING VITREOUS OPACITIES IN THE PROJECTION OF THE VISUAL AXIS IN PATIENTS WITHOUT MACULAR PATHOLOGY AFTER PERFORMING ND:YAG LASER VITREOLYSIS | 2017 |
|
RU2661016C1 |
| METHOD OF TREATING RETICULAR PSEUDO-DRUSEN WITH MICRO-PULSE LASER ACTION | 2018 |
|
RU2696927C1 |
| METHOD OF COMBINED LASER TREATMENT OF DRUSENOID SEPARATION OF RETINAL PIGMENT EPITHELIUM | 2019 |
|
RU2727035C1 |
| METHOD OF TREATMENT OF MORPHOFUNCTIONAL DISTURBANCE OF CENTRAL ZONE OF RETINA FOLLOWING VITREORETINAL SURGERY OF RETINAL DETACHMENT | 2008 |
|
RU2381774C1 |
| METHOD FOR SURGICAL MANAGEMENT OF MACULAR RUPTURE USING AUTOLOGOUS CONDITIONED PLASMA | 2023 |
|
RU2816630C1 |
| METHOD OF TREATING RETICULAR PSEUDO-DRUSEN | 2019 |
|
RU2727034C1 |
| METHOD OF TREATING IDIOPATHIC MACULAR RUPTURE | 2009 |
|
RU2393828C1 |
